VERU Veru Inc
Company Analysis
Latest News
🟢 Veru is trading 5.1% up today, extending gains on Novo Nordisk obesity trial supply deal
Veru is trading 5.1% up today at $2.38, continuing a multi-day rebound following its clinical supply agreement with Novo Nordisk for the PLATEAU Phase 2b...
🟢 Veru is trading 5.1% up today after exceeding enrollment for Phase 2b obesity trial
Veru is trading 5.1% up at $2.37 after announcing it has completed and exceeded enrollment for its Phase 2b PLATEAU trial of oral enobosarm plus semaglutide in...
Veru Completes Enrollment for Phase 2b Weight-Loss Drug Trial
Veru Inc. completed and exceeded its targeted enrollment of 200 patients for the Phase 2b PLATEAU clinical trial. The study evaluates oral enobosarm combined...
🟢 Veru is trading 5.8% up today amid a modest risk-on tone in U.S. futures
Veru is trading 5.78% up at $2.38 in pre-market action, though no company-specific catalysts have been identified to explain the move. • The price action...
🔴 Veru is trading 5.2% down today amid broad biotech and market weakness
Veru is trading 5.2% down at $2.29, giving back part of yesterday’s bounce as the stock tracks a broader market decline. • There are no fresh company-specific...
🔴 Veru is trading 5.1% down today on continued post-rally profit-taking
Veru is trading 5.1% down at $2.43 as investors continue to lock in gains following its recent Novo Nordisk clinical supply deal and strong Q2 fiscal 2026...
🔴 Veru is trading 5% down today on profit-taking after Novo Nordisk-driven rally
Veru is trading approximately 5% down today at $2.64 as the stock undergoes a period of consolidation following a recent rally fueled by a Novo Nordisk...
🔴 Veru is trading 5.2% down today on profit-taking after recent Novo Nordisk-driven rally
Veru is trading 5.2% down at $2.67 today as the stock undergoes profit-taking and consolidation following its recent sharp rally. • The previous multi-day...
🟢 VERU is trading 5.5% up today, rebounding from a prior-session drop and after-hours momentum
VERU is trading 5.5% up at $2.81 as it rebounds from yesterday's decline and continues its after-hours momentum. • The stock is recovering from a 7.6% drop in...
🟢 Veru Inc is trading 7.95% up in after-hours
VERU is trading at $2.87, up 7.95% in after-hours.
🔴 VERU extends move to 5.2% down
VERU is trading at $2.73, down 5.2% versus the comparison close of $2.88 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 VERU is trading 6.25% down today amid continued volatility
VERU is trading at $2.70 (-6.25%) following a sharp early-session drop, which appears to be a continuation of recent volatility. • No major company-specific...
🟢 Veru Inc is trading 6.39% up
VERU is trading at $3.33, up 6.39%.
🟢 VERU is trading 6.3% up today, extending a rebound, also added to Russell Microcap Value Benchmark Index
VERU is trading at $3.20 (6.3% up), extending a rebound following its early-June spike on a Novo Nordisk clinical supply deal. • The company was added to the...
🔴 Veru Inc is trading 5% down today with no clear catalyst yet
Veru Inc is trading 5% down at $2.84 today, underperforming a broadly positive market backdrop despite a lack of fresh company-specific headlines. • The...
🔴 Veru Inc is trading 5.3% down today as it gives back part of last week's gains
Veru Inc is trading 5.3% down today at $2.96 as the stock retreats following a sharp rebound last week. • The decline occurred on light liquidity with no...
🔴 Veru Inc is trading 6.2% down today with no clear catalyst amid light pre-market liquidity
Veru Inc is trading 6.2% down at $2.94 in pre-market sessions with no clear catalyst for the move. • The decline gives back a portion of the June 15 rebound...
🟢 Veru Inc is trading 5.2% up today, rebounding amid broad risk-on market sentiment
Veru Inc is trading 5.2% higher at $3.15, recovering a portion of last week’s steep pullback following a Novo Nordisk-driven rally. • The move appears tied to...
🔴 Veru Inc is trading 5.4% down today on profit-taking after its recent Novo Nordisk-driven rally
Veru Inc is trading at $3.08 (-5.37%) as the stock faces profit-taking following a sharp rally tied to its clinical supply agreement with Novo Nordisk. • The...
🟢 Veru Inc is trading 9% up today on its obesity-trial supply deal with Novo Nordisk
Veru Inc is trading at $3.21 (+8.98%) as shares continue to react to a clinical supply agreement with Novo Nordisk for the enobosarm obesity trial. * The...